the portuguese version of rhinitis and asthma patient s perspective rapp validation and assessment

Abstract Background Allergic rhinitis (AR) and asthma are two common chronic diseases that often coexist. There is a need for a validated tool to evaluate HRQoL of Portuguese speakers with asthma and/or rhinitis patients in clinical practice. Objectives To adapt and validate RhinAsthma Patient Perspective (RAPP) in Portuguese. Methods The RAPP questionnaire was translated into Portuguese. Asthmatics with comorbidities and rhinitis attending the allergy department of Coimbra University Hospital were asked to complete the Portuguese translation of RAPP, in addition to the SF-12, ACT, and a Symptomatologic VAS twice, with a 4-week interval between visits. During Visit 2, a Global Rating Scale (GRS) was completed to assess any change in health status. Scale dimensions, internal consistency and convergent validity, reliability, discriminant ability and responsiveness to change, as well as Minimal Clinical Difference were assessed. Results Factor and confirmatory analysis confirm the unidimensional structure of the questionnaire. Internal consistency has been shown to be satisfactory (0.82 visit 1 and 0.86 at visit 2). The tool is able to discriminate between patients on the basis of asthma severity, asthma control level, and rhinitis severity; convergent validity showed a significant correlation with SF-2 Physical component (r = −0.46 and 0.42, p at Visits 1 and 2). An ICC of 0.97 and a CCC = 0.94 indicate that the tool is highly reliable. Responsiveness was shown in detecting a significant association with GRS changes (r = 0.41, p Conclusions The Portuguese version of RAPP has been demonstrated to have good measurement properties and sensitivity to health changes, which will provide a valid, reliable and standardized HRQoL measurement in patients with asthma and comorbid allergic rhinitis in clinical practice

Sensitisation patterns in legume hypersensitivity. A study from the central region of Portugal

Background: Foods from the legume family are used in the Mediterranean diet as a source of protein. In some cases, their ingestion triggers potentially life -threatening reactions. A high degree of immunological cross-reactivity has been described, but its clinical relevance is controversial. Aim: To carry out a clinical and laboratory characterisation of patients sensitised to leguminosae who had symptoms after the ingestion of at least one food from the leguminosae botanical family. Methods: We selected 13 consecutive patients from a food allergy outpatient clinic with allergy symptoms after the ingestion of leguminosae during the year of 2006. Case history data, skin prick tests (SPT) with commercial extracts of white bean, green bean, pea, chickpea, soya bean and peanut, and prick-to-prick (PP) tests to these legumes, both raw and boiled, and also to lupini bean and black -eyed bean were performed. Serum specific IgE and immunoblotting assays were also carried out. Results: Most patients had had symptoms with more than one legume (mean 3 legumes) with bean the most reported. The first culprit leguminosae reported was chickpea in 4 patients, bean in 4 patients and lupini bean in 3. Sensitisation to other legumes without clinical symptoms also occurred (mean 2 legumes). Anaphylaxis was described in 3 patients, to bean, soya and lupini bean, respectively. Asthma was connected to chickpea (2 patients) and to bean (1). One or more of the following symptoms: urticaria, angiooedema and oral allergy syndrome were reported by other patients. Symptomatic patients always had positive PP tests to leguminosae and most SPT were also positive. Conclusions: Lifethreatening reactions to leguminosae were found. PP tests used alone to raw and boiled legumes seem to be the most reliable diagnostic tests as in the case of other vegetable foods. However, immunoblotting assays are still important in the identification of new allergens

Clinical and immunological patterns in patients with shrimp hypersensitivity and Dermatophagoides pteronyssinus cross-reactivity

Objectivos: Investigar padrões clínicos em doentes com hipersensibilidade a camarão e a ocorrência de reactividade cruzada a Dermatophagoides pteronyssinus (Dp). Caracterizar as principais proteínas envolvidas na reactividade a camarão, em estudos de immunoblotting. Métodos: Avaliaram-se 20 doentes com clínica de hipersensibilidade imediata, após ingestão de camarão. Aplicou-se um questionário estandardizado, foram efectuados testes cutâneos por prick a alimentos e aeroalergénios e procedeu-se à determinação de IgE específica a camarão e Dp por UniCap e immunoblotting. A existência de eventual reactividade cruzada imunológica entre camarão e Dp foi investigada por estudos de inibição de immunoblotting. Resultados: A média de idades dos doentes era de 33±16 anos, sendo 13 do sexo masculino. As manifestações clínicas após ingestão de camarão foram urticária e/ou angioedema generalizados em 8 doentes, síndrome de alergia oral em 9 e anafilaxia em 3. Para além do camarão, foi detectada em todos os doentes sensibilização a outros crustáceos com sintomas semelhantes. Outros alimentos reportados em que se confirmou sensibilização foram moluscos -12 doentes e ovo -1. Em todos os doentes foi detectada sensibilização a Dp e sensibilização associada a barata em 12, a pólenes em 13, a cão em 5 e a gato em 5. Doseamentos de IgE específica a Dp e camarão superiores ou iguais a 3,5 KU/l foram encontrados, respectivamente, em 15 e 12 doentes. Considerando os estudos de immunoblotting a camarão, observou-se uma maior intensidade de ligação a bandas com peso molecular (PM) de 35 -40 KDa em 14 doentes, 17 KDa em 2, 22 KDa em um e 43-50 KDa nos restantes 3. Os estudos de inibição de immunoblotting evidenciaram reactividade cruzada em 15 doentes, recíproca camarão - Dp em 10 e não recíproca em 5, não sendo possível demonstrar a sua existência em 5. Conclusões: O PM encontrado para as bandas de maior intensidade nos estudos de immunoblotting a camarão sugere o envolvimento de tropomiosinas na maioria dos doentes, reforçando o papel destes panalergénios como alergénios major na hipersensibilidade a camarão em doentes sensibilizados a ácaros. Sensibilização simultânea a camarão e Dp pode ocorrer na ausência de reactividade cruzada e diferentes padrões de sensibilização deverão ser considerados

Clinical and immunological patterns in patients with shrimp hypersensitivity and Dermatophagoides pteronyssinus cross-reactivity

Objectivos: Investigar padrões clínicos em doentes com hipersensibilidade a camarão e a ocorrência de reactividade cruzada a Dermatophagoides pteronyssinus (Dp). Caracterizar as principais proteínas envolvidas na reactividade a camarão, em estudos de immunoblotting. Métodos: Avaliaram-se 20 doentes com clínica de hipersensibilidade imediata, após ingestão de camarão. Aplicou-se um questionário estandardizado, foram efectuados testes cutâneos por prick a alimentos e aeroalergénios e procedeu-se à determinação de IgE específica a camarão e Dp por UniCap e immunoblotting. A existência de eventual reactividade cruzada imunológica entre camarão e Dp foi investigada por estudos de inibição de immunoblotting. Resultados: A média de idades dos doentes era de 33±16 anos, sendo 13 do sexo masculino. As manifestações clínicas após ingestão de camarão foram urticária e/ou angioedema generalizados em 8 doentes, síndrome de alergia oral em 9 e anafilaxia em 3. Para além do camarão, foi detectada em todos os doentes sensibilização a outros crustáceos com sintomas semelhantes. Outros alimentos reportados em que se confirmou sensibilização foram moluscos -12 doentes e ovo -1. Em todos os doentes foi detectada sensibilização a Dp e sensibilização associada a barata em 12, a pólenes em 13, a cão em 5 e a gato em 5. Doseamentos de IgE específica a Dp e camarão superiores ou iguais a 3,5 KU/l foram encontrados, respectivamente, em 15 e 12 doentes. Considerando os estudos de immunoblotting a camarão, observou-se uma maior intensidade de ligação a bandas com peso molecular (PM) de 35 -40 KDa em 14 doentes, 17 KDa em 2, 22 KDa em um e 43-50 KDa nos restantes 3. Os estudos de inibição de immunoblotting evidenciaram reactividade cruzada em 15 doentes, recíproca camarão - Dp em 10 e não recíproca em 5, não sendo possível demonstrar a sua existência em 5. Conclusões: O PM encontrado para as bandas de maior intensidade nos estudos de immunoblotting a camarão sugere o envolvimento de tropomiosinas na maioria dos doentes, reforçando o papel destes panalergénios como alergénios major na hipersensibilidade a camarão em doentes sensibilizados a ácaros. Sensibilização simultânea a camarão e Dp pode ocorrer na ausência de reactividade cruzada e diferentes padrões de sensibilização deverão ser considerados

Asthma-COPD overlap: A Portuguese survey

Introduction: The overlap between asthma and chronic obstructive pulmonary disease (COPD) (ACO) has been discussed for many years but clinical recommendations for this entity have been diverse. This study is intended to reach a consensus on diagnosis, treatment and patient orientation for ACO, within the Portuguese medical community. Methods: This study was conducted by a multidisciplinary panel of experts from three distinct medical specialties (Pulmonology, Family Medicine and Immunoallergology). This panel selected a total of 190 clinicians, based on their expertise in obstructive airway diseases, to participate in a Delphi structured survey with three rounds of questionnaires. These results were ultimately discussed, in a meeting with the panel of experts and some of the study participants, and consensus was reached in terms of classification criteria, treatment and orientation of ACO patients. Results: The majority of clinicians (87.2%) considered relevant the definition of an overlap entity between asthma and COPD. A consensus was achieved on the diagnosis of ACO – presence of simultaneous clinical characteristics of asthma and COPD together with a fixed airflow obstruction (FEV1/FVC 300 eosinophils/μL or >5% of leukocytes); elevation of specific IgEs or positive skin tests for common allergens). A combination of inhaled corticosteroid (ICS) with long-acting beta2-agonist (LABA) or long-acting muscarinic antagonist (LAMA) was considered as first line pharmacological treatment. Triple therapy with ICS plus LABA and LAMA should be used in more severe or symptomatic cases. Non-pharmacological treatment, similar to what is recommended for asthma and COPD, was also considered highly important. A hospital referral of ACO patients should be made in symptomatic or severe cases or when there is a lack of diagnostic resources. Conclusions: This study highlights the relevance of defining ACO, within the Portuguese medical community, and establishes diagnostic criteria that are important for future interventional studies. Recommendations on treatment and patient's orientation were also achieved.Actelion Pharmaceuticals (undefined)info:eu-repo/semantics/publishedVersio

Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper

The aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations for patient-reported outcomes (PROs) evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological economic and social impact. During the last 40 years, PROs have gained large consideration and use in the scientific community, to gain a better understanding of patients' subjective assessment with respect to elements concerning their health condition. They include all health-related reports coming from the patient, without involvement or interpretation by physician or others. PROs assessment should be performed by validated tools (disease-specific tools when available or generic ones) selected taking into account the aim of the study, the expected intervention effects and the determinant and confounding factors or patient-related factors which could influence PROs. Moreover, each tool should be used exclusively in the patient population following the authors' indications without modification and performing a cross-cultural validation if the tool must be used in a language that differs from the original. The result analysis also suggests that the relevance of PROs results in any interventional study should include a pre-post assessment providing information concerning statistical differences within or among groups, rates of response for the PROs and a minimal important difference for the population. The report underlines the importance of further investigation on some topics, such as the quality assessment of existing PROs tools, the definition of inclusion and exclusion criteria and a more extensive evaluation of the correlation between PROs, besides health-related quality of life, and clinical data

Dietary Intake of Flavonoids and Ventilatory Function in European Adults : A GA(2)LEN Study

Background: Flavonoids exert anti-inflammatory properties and modulate oxidative stress in vitro, suggesting a protective effect on lung function, but epidemiological studies examining this association are scarce. Methods: A stratified random sample was drawn from the GA(2)LEN screening survey, in which 55,000 adults aged 15 to 75 answered a questionnaire on respiratory symptoms. Post-bronchodilator spirometry was obtained from 2850 subjects. Forced vital capacity (FVC), the ratio between the forced exhaled volume in 1 second (FEV1) and FVC (FEV1/FVC), FVC below lower limit of normal (FVC <LLN), and FEV1/FVC <LLN were calculated. Intake of the six main subclasses of flavonoids was estimated using the GA(2)LEN Food Frequency Questionnaire. Adjusted associations between outcomes and each subclass of flavonoids were examined with multivariate regressions. Simes' procedure was used to test for multiple comparisons. Results: A total of 2599 subjects had valid lung function and dietary data. A lower prevalence of FVC <LLN (airway restriction) was observed in those with higher total flavonoid (adjusted odds ratio (aOR), higher vs. lowest quintile intake 0.58; 95% Confidence Interval (CI) 0.36, 0.94), and pro-anthocyanidin intakes (aOR 0.47; 95% CI 0.27, 0.81). A higher FEV1/FVC was associated with higher intakes of total flavonoids and pro-anthocyanidins (adjusted correlation coefficient (a -coeff 0.33; 0.10, 0.57 and a -coeff 0.44; 95% CI 0.19, 0.69, respectively). After Simes' procedure, the statistical significance of each of these associations was attenuated but remained below 0.05, with the exception of total flavonoids and airway restriction. Conclusions: This population-based study in European adults provides cross-sectional evidence of a positive association of total flavonoid intake and pro-anthocyanidins and ventilatory function, and a negative association with spirometric restriction in European adults.Peer reviewe

Is fruit and vegetable intake associated with asthma or chronic rhino-sinusitis in European adults? Results from the Global Allergy and Asthma Network of Excellence (GA(2)LEN) Survey

Background: Fruits and vegetables are rich in compounds with proposed antioxidant, anti-allergic and anti-inflammatory properties, which could contribute to reduce the prevalence of asthma and allergic diseases. Objective: We investigated the association between asthma, and chronic rhino-sinusitis (CRS) with intake of fruits and vegetables in European adults. Methods: A stratified random sample was drawn from the Global Allergy and Asthma Network of Excellence (GA(2)LEN) screening survey, in which 55,000 adults aged 15-75 answered a questionnaire on respiratory symptoms. Asthma score (derived from self-reported asthma symptoms) and CRS were the outcomes of interest. Dietary intake of 22 subgroups of fruits and vegetables was ascertained using the internationally validated GA(2)LEN Food Frequency Questionnaire. Adjusted associations were examined with negative binomial and multiple regressions. Simes procedure was used to control for multiple testing. Results: A total of 3206 individuals had valid data on asthma and dietary exposures of interest. 22.8% reported having at least 1 asthma symptom (asthma score >= 1), whilst 19.5% had CRS. After adjustment for potential confounders, asthma score was negatively associated with intake of dried fruits (beta-coefficient -2.34;95% confidence interval [CI] -4.09,-0.59), whilst CRS was statistically negatively associated with total intake of fruits (OR 0.73; 95% CI 0.55, 0.97). Conversely, a positive association was observed between asthma score and alliums vegetables (adjusted beta-coefficient 0.23; 95% CI 0.06, 0.40). None of these associations remained statistically significant after controlling for multiple testing. Conclusion and clinical relevance: There was no consistent evidence for an association of asthma or CRS with fruit and vegetable intake in this representative sample of European adults.Peer reviewe

Monitoring Adherence to Asthma Inhalers Using the InspirerMundi App: Analysis of Real-World, Medium-Term Feasibility Studies

Background: Poor medication adherence is a major challenge in asthma and objective assessment of inhaler adherence is needed. InspirerMundi app aims to monitor inhaler adherence while turning it into a positive experience through gamification and social support. Objective: We assessed the medium-term feasibility of the InspirerMundi app to monitor inhaler adherence in real-world patients with persistent asthma (treated with daily inhaled medication). In addition, we attempted to identify the characteristics of the patients related to higher app use. Methods: Two real-world multicenter observational studies, with one initial face-to-face visit and a 4-month telephone interview, were conducted in 29 secondary care centers from Portugal. During an initial face-to-face visit, patients were invited to use the app daily to register their asthma medication intakes. A scheduled intake was considered taken when patients took a photo of the medication (inhaler, blister, or others) using the image-based medication detection tool. Medication adherence was calculated as the number of doses taken as a percentage of the number scheduled. Interacting with the app ≥30 days was used as the cut-off for higher app use. Results: A total of 114 patients {median 20 [percentile 25 to percentile 75 (P25-P75) 16-36] years, 62% adults} were invited, 107 (94%) installed the app and 83 (73%) completed the 4-month interview. Patients interacted with the app for a median of 18 [3-45] days, translated on a median use rate of 15 [3-38]%. Median inhaler adherence assessed through the app was 34 [4-73]% when considering all scheduled inhalations for the study period. Inhaler adherence assessed was not significantly correlated with self-reported estimates. Median adherence for oral and other medication was 41 [6-83]% and 43 [3-73]%, respectively. Patients with higher app use were slightly older (p = 0.012), more frequently taking medication for other health conditions (p = 0.040), and more frequently prescribed long-acting muscarinic antagonists (LAMA, p = 0.024). After 4 months, Control of Allergic Rhinitis and Asthma Test (CARAT) scores improved (p < 0.001), but no differences between patients interacting with the app for 30 days or less were seen. Conclusions: The InspirerMundi app was feasible to monitor inhaler adherence in patients with persistent asthma. The persistent use of this mHealth technology varies widely. A better understanding of characteristics related to higher app use is still needed before effectiveness studies are undertaken.info:eu-repo/semantics/publishedVersio

Asthma App Use and Interest Among Patients With Asthma: A Multicenter Study

info:eu-repo/semantics/publishedVersio